News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Vivex Biomedical Raises $7.4 Million


9/18/2013 7:53:51 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

A biomedical startup that focuses on implant technology and stem cell therapies has raised $7.4 million, according to a Securities and Exchange Commission filing. Vivex Biomedical Inc. is developing implant technology to help stimulate bone regrowth. Vivex has also licensed a highly adaptive adult stem cell line, known as MIAMI (Marrow Isolated Adult Multi-lineage Inducible) cells. With its implant and stem cell technology, Vivex plans to target patients with spinal cord injuries, orthopedic injuries and traumatic wounds.

Help employers find you! Check out all the jobs and post your resume.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES